Brief: Knight Therapeutics Inc - QTRLY Basic Net Loss Per Share $0.01
26/06/2020 13:56
Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS REPORTS FIRST QUARTER 2020 RESULTS
* KNIGHT THERAPEUTICS INC - QTRLY BASIC NET LOSS PER SHARE
$0.01
Source text for Eikon: ID:nGNX44PYB0
Further company coverage: GUD.TO
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil